1991
DOI: 10.1016/s0161-6420(91)32135-3
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy and Tolerance of Intravitreal Ganciclovir in Cytomegalovirus Retinitis in Acquired Immune Deficiency Syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
37
2
1

Year Published

1992
1992
2010
2010

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 154 publications
(40 citation statements)
references
References 38 publications
0
37
2
1
Order By: Relevance
“…However, frequent intravitreal injections are required to maintain therapeutic levels of GCV due to the short half-life of the drug. These continuous administrations bring about the risk of retinal detachments, hemorrhages, or endophthalmitis [6]. Hence, a sustained release by a biodegradable device would decrease these risks and produce a longer therapeutic effect.…”
Section: Introductionmentioning
confidence: 99%
“…However, frequent intravitreal injections are required to maintain therapeutic levels of GCV due to the short half-life of the drug. These continuous administrations bring about the risk of retinal detachments, hemorrhages, or endophthalmitis [6]. Hence, a sustained release by a biodegradable device would decrease these risks and produce a longer therapeutic effect.…”
Section: Introductionmentioning
confidence: 99%
“…Other toxic effects include granulocytopenia, thrombocytopenia, azoospermia, and rise in the serum creatinine (Faulds and Heel, 1990). Relatively high systemic toxicity caused by intravenous therapy has lead to the intravitreal administration of GCV (Henry et al, 1987;Daikos et al, 1988;Ussery et al, 1988;Cantrill et al, 1989;Cochereau-Massin et al, 1991), which enabled considerable improvement and/or stabilization of HCMV retinitis in most (80 -100%) of the patients. Intravitreal administration has the advantage of maintaining high concentrations of the drug for effective control of ocular infections with minimal systemic adverse effects.…”
mentioning
confidence: 99%
“…Intravitreal administration has the advantage of maintaining high concentrations of the drug for effective control of ocular infections with minimal systemic adverse effects. Clinical trials reported good response rates to intravitreal induction therapy with GCV (Cochereau-Massin et al, 1991). However, very few studies have been carried out to date delineating the intravitreal pharmacokinetics of GCV (Henry et al, 1987;Ashton et al, 1992;Morlet et al, 1996).…”
mentioning
confidence: 99%
“…Além da endoftalmite bacteriana, a retinite viral por citomegalovírus também requer tratamento com injeção intravítrea, neste caso com ganciclovir. Realizada sob condições de assepsia, é considerada a mais eficiente via de administração de medicamentos para o tratamento de doenças inflamatórias, infecciosas e proliferativas do segmento posterior (1,3,(20)(21) . Medicamentos hidrofílicos introduzidos no vítreo são preferencialmente eliminados através da hialóide anterior para a câmara anterior e para fora do olho pela drenagem pelo trabeculado.…”
Section: Via Intravítrea De Adminstração De Fármacosunclassified